-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Crinetics Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2017 to Q2 2024.
- Crinetics Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $18.9M, a 86.1% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $55.1M, a 63.6% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.9M, a 44.8% increase from 2022.
- Crinetics Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28.3M, a 62.9% increase from 2021.
- Crinetics Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $17.4M, a 66.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)